Validation of a Bedside Dengue Severity Score for Prediction of Severe Dengue in Paediatric Patients: A Cross-Sectional Study
International Journal of Current Pharmaceutical Review and Research · 31.03.2026 · 18 (03)
DOI: 10.25258/ijcpr.18.3.119 ↗Kurz gefasst
Querschnittstudie in der Zeitschrift International Journal of Current Pharmaceutical Review and Research, online erschienen am 31.03.2026. Verfasst von Divya Yadav und 4 weiteren Autor:innen.
Abstract (Originalsprache)
Background
Dengue fever is a major mosquito-borne viral infection affecting children in tropical countries such as India. Early identification of severe dengue is essential to prevent complications and improve outcomes. The Bedside Dengue Severity Score (BDSS) is a simple clinical tool developed to predict disease severity using easily observable bedside parameters.
Objective
The present study aimed to validate the Bedside Dengue Severity Score in paediatric dengue patients and compare its diagnostic performance with WHO-2022 and NVBDCP-2023 dengue severity classifications.
Methods
A hospital-based cross-sectional study was conducted in the Inpatient Department of Rohilkhand Medical College and Hospital, Bareilly, Uttar Pradesh, over a period of one year. A total of 80 children aged 118 years with laboratory-confirmed dengue infection were included. Among them, 30 patients were classified as severe dengue and 50 as non-severe dengue according to WHO-2022/NVBDCP-2023 criteria. Clinical features, laboratory parameters, hemodynamic variables, BDSS score, and outcomes were recorded and analyzed. The diagnostic performance of BDSS was evaluated using sensitivity, specificity, positive predictive value, negative predictive value, and accuracy.
Results
Severe dengue patients showed significantly lower platelet counts (31.4 ± 11.88 vs 106.2 ± 49.7 ×10³/µL) and higher hematocrit levels (46.8 ± 4.1% vs 38.4 ± 3.6%) compared to non-severe cases. Clinical warning signs, third-space fluid loss, and hemodynamic instability were significantly more common among severe dengue patients. Higher BDSS scores were strongly associated with severe dengue (p = 0.001). BDSS demonstrated a sensitivity of 47.37%, specificity of 98.36%, positive predictive value of 90.00%, negative predictive value of 85.71%, and overall diagnostic accuracy of 86.25%.
Conclusion
The Bedside Dengue Severity Score is a simple and reliable clinical tool for early identification of severe dengue in paediatric patients and may assist clinicians in rapid risk stratification, particularly in resourcelimited settings.
Zitieren
APA
Yadav, D., Gautam, N., Gangwar, S., Bansal, S., & Rai, P. L. (2026). Validation of a Bedside Dengue Severity Score for Prediction of Severe Dengue in Paediatric Patients: A Cross-Sectional Study. International Journal of Current Pharmaceutical Review and Research, 18(03). https://doi.org/10.25258/ijcpr.18.3.119
Vancouver
Yadav D, Gautam N, Gangwar S, Bansal S, Rai PL. Validation of a Bedside Dengue Severity Score for Prediction of Severe Dengue in Paediatric Patients: A Cross-Sectional Study. International Journal of Current Pharmaceutical Review and Research. 2026;18(03). doi:10.25258/ijcpr.18.3.119
BibTeX
@article{Yadav2026,
author = {Yadav, Divya and Gautam, Neetu and Gangwar, Somesh and Bansal, Shivani and Rai, Preeti Lata},
title = {Validation of a Bedside Dengue Severity Score for Prediction of Severe Dengue in Paediatric Patients: A Cross-Sectional Study},
journal = {International Journal of Current Pharmaceutical Review and Research},
year = {2026},
volume = {18},
number = {03},
doi = {10.25258/ijcpr.18.3.119}
}
EUVIMED